ITGAL and head and neck squamous cell carcinoma: Importantly, our research findings suggested that the efficacy of Anti-PD-1/PD-L1 and Anti-PD-1 on HNSCC was closely linked to the ITGAL expression; and those with high ITGAL expression were more likely efficient in Anti-PD-1/PD-L1.